Don't miss Joystiq's up-to-the-minute live coverage of E3!

AOL Money & Finance

IPO & secondary preview: Week of Feb. 26, 2007

Posted Feb 26th 2007 3:15PM by Joseph Lazzaro
Filed under: SEC filings, Other issues, Competitive strategy

Wall Street's equity market continues in light-schedule mode this week, with just 2 IPOs and 2 Secondaries on the docket.

Those deals tentatively scheduled to price include:

IPOs:

Tuesday

Churchill Ventures (CHV), a 12.5 million-share IPO for this special purposes corporation. The Bank of America is the lead manager. Filing price: $8.

OncoGenex Technologies (OGXI), a 4.5 million-share IPO for this anti-cancer medicine company. RCB Capital Markets is the lead manager. Filing range: $10-$12.


Secondaries:

Tuesday

Rosetta Genomics (ROSG), a 3.75 million-share Secondary for this gene-based medical company. CE Unterberg is the lead manager.

Friday

Mylan Laboratories (MYL), a 21.5 million-share Secondary for this pharmaceutical company. Merrill Lynch and JP Morgan Chase are the lead managers.

For the latest market intelligence on IPOs, Syndicate, and after-market trades, check out TheFLY Syndicate at www.theflyonthewall.com. (Subscription required.)

Tags: MylanLaboratories

  • Permalink
  • Email this
  • Print this
  • Comments [0]
Symbol Lookup
IndexesChangePrice
DJIA-344.6511,188.23
NASDAQ-74.692,259.04
S&P 500-38.151,236.83

Last updated: September 05, 2008: 01:40 AM

BloggingStocks Exclusives

Hot Stocks

BloggingStocks Featured Video

TheFlyOnTheWall.com Headlines

WalletPop Headlines

AOL Business News

Latest from BloggingBuyouts

Sponsored Links

Most Commented On (14 days)

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

  • My Portfolio
  • Create a New Portfolio

BloggingStocks Partners

More from AOL Money & Finance

Weblogs, Inc. Network